DesRosiers Caleb bought DXR
June 23, 2026 · Form 4 insider transaction
DesRosiers Caleb bought 2,500 shares of Daxor Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,500
Price
$0.00
Total value
N/A
InsiderDesRosiers Caleb
Role—
CompanyDaxor Corporation (DXR)
SecurityStock options (right to buy)
Transaction codeA: Grant or award
Transaction dateJune 23, 2026
Filing dateJune 25, 2026
Shares owned after2,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Stock options granted on June 23, 2026 are contingent on the approval of the Securities & Exchange Commission ("SEC") to amend the Daxor Corporation 2020 Incentive Compensation Plan (the "Plan"); The stock options will vest in three (3) installments - June 23, 2026 (833); June 23, 2027 (833); June 23, 2028 (834)